Form 4: Penumbra Inc. CEO Adam Elsesser Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Penumbra Inc.'s CEO, Adam Elsesser, exercised stock options and sold shares of common stock on May 7, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On May 7, 2025, Adam Elsesser, CEO and President of Penumbra Inc., executed a stock option to acquire 27,976 shares at $30 per share.
- Simultaneously, Elsesser sold a total of 12,690 shares of Penumbra's common stock in multiple transactions at prices ranging from $287.26 to $295.
- These sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which was established in connection with the expiration of certain stock options and to cover the exercise price and tax obligations.
- Following these transactions, Elsesser directly owns 75,237 shares of common stock and indirectly owns 837,582 shares through a trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of Penumbra's CEO. It is common for executives to use 10b5-1 plans to manage their stock holdings and avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a form of long-term incentive.
- Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock sales in compliance with insider trading regulations.
- The reported transactions are similar to those of executives at comparable medical device companies, such as Medtronic or Stryker, who regularly exercise options and sell shares.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
- The use of a 10b5-1 plan ensures compliance with insider trading regulations, which is beneficial for maintaining investor confidence.
Key Dates
| Date | Description |
|---|---|
| 05/07/2025 | Date of stock option exercise and share sales. |
| 05/09/2025 | Date of Form 4 filing. |
| 09/16/2025 | Expiration date of stock options. |
Keywords
Form 4, Penumbra Inc, Adam Elsesser, Stock Options, Rule 10b5-1, Insider Trading, Share Sales
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.